Canopy Immuno-Therapeutics

Advancing beyond immunosuppression, Striving towards curing autoimmunity.

Haifa, Israel · Founded 2020

Headquarters
Haifa
Employees
1–10
Founded
2020
Business Model
B2B
Last Round
SeedDec 2019
Rounds
1

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Canopy Immuno-Therapeutics is a clinical-stage biotechnology company developing antigen-drug conjugates (AgDCs), a novel class of non-immunosuppressive biologics designed to selectively eliminate pathological antibodies and autoreactive B-cells in antibody-mediated autoimmune diseases. Founded in 2020 by Dr. Kfir Oved, a serial bio-entrepreneur with dual training in medicine and immunology, the company operates in stealth mode from Israel and uses its proprietary Reverse Immunization platform to target specific autoimmune conditions including Myasthenia Gravis without the broad immunosuppression of existing therapies. Canopy is backed by investors and affiliated with JLABS Singapore.

Summary

Canopy Immuno-Therapeutics is a Biotech company based in Haifa, Israel, founded in 2020. Its most recent funding was a Seed round in Dec 2019. Investors include Morningside Group and TLV Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundDec 2019

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Canopy Immuno-Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/canopy-immuno-therapeutics"><img src="https://indexed.vc/api/badge/company/canopy-immuno-therapeutics" alt="Canopy Immuno-Therapeutics on Indexed.vc" width="260" height="76" /></a>